Rare diseases
Investigational molecules
Locations
Back to France2 598 clinical trials in Paris, France across 36 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Milvexian and Drug Combination for Patients Recovering from a Heart Attack
FranceStudy on Vixarelimab for Patients with Idiopathic Pulmonary Fibrosis and Systemic Sclerosis-Associated Interstitial Lung Disease
FranceStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
FranceStudy on Inclisiran for Preventing Heart Disease in High-Risk Patients
FranceStudy on the Effects of Pegozafermin and Simvastatin for Patients with Severe High Triglycerides
FranceStudy on Tulisokibart for Treating Moderate to Severe Crohn's Disease in Adults
FranceFranceSafety and tolerability of intrathecal S233107 in participants with spinocerebellar ataxia type 3: a Phase 1b/2a first‑in‑human randomized study
FranceWeight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone
FranceOpen‑Label Extension Study of Avutometinib Alone or with Defactinib in Patients with Recurrent Low‑Grade Serous Ovarian Cancer
FranceStudy of Atezolizumab with Lenvatinib or Sorafenib vs Lenvatinib or Sorafenib alone in Unresectable Hepatocellular Carcinoma after Atezolizumab and Bevacizumab
FrancePhase 2 Study of Daxdilimab with Prednisone in Adults with Inadequately Controlled Dermatomyositis or Anti‑Synthetase Inflammatory Myositis
FranceThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on head and neck squamous cell carcinoma and endometrial cancer, evaluating innovative treatment combinations and survival outcomes.
Clinical investigations targeting Type 1 Diabetes and obesity, with novel therapeutic approaches using tirzepatide for improved glycemic control.
Innovative vaccine trials for COVID-19, influenza, and cytomegalovirus, exploring both intranasal and injectable delivery methods.
Advanced research in multiple sclerosis and Alzheimer's disease, utilizing cutting-edge imaging techniques to study neuroinflammation and synaptic density.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
